Simulations Plus, Inc. (NASDAQ:SLP) Director Walter S. Woltosz Sells 20,000 Shares

Simulations Plus, Inc. (NASDAQ:SLP) Director Walter S. Woltosz sold 20,000 shares of Simulations Plus stock in a transaction dated Thursday, August 1st. The shares were sold at an average price of $39.63, for a total transaction of $792,600.00. Following the transaction, the director now directly owns 3,521,592 shares of the company’s stock, valued at $139,560,690.96. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink.

Simulations Plus Stock Down 3.5 %

Shares of SLP stock opened at $38.60 on Monday. Simulations Plus, Inc. has a 12-month low of $32.69 and a 12-month high of $52.69. The firm has a fifty day moving average of $44.25 and a 200-day moving average of $43.92. The company has a market capitalization of $772.39 million, a price-to-earnings ratio of 80.42 and a beta of 0.72.

Simulations Plus (NASDAQ:SLP) last announced its quarterly earnings data on Tuesday, July 2nd. The technology company reported $0.19 EPS for the quarter, topping analysts’ consensus estimates of $0.15 by $0.04. Simulations Plus had a net margin of 14.36% and a return on equity of 7.80%. The business had revenue of $18.54 million for the quarter, compared to analyst estimates of $17.92 million. During the same quarter in the previous year, the firm posted $0.20 earnings per share. The firm’s revenue for the quarter was up 14.2% on a year-over-year basis. On average, equities analysts expect that Simulations Plus, Inc. will post 0.52 EPS for the current year.

Simulations Plus Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Monday, August 5th. Stockholders of record on Monday, July 29th will be issued a $0.06 dividend. The ex-dividend date of this dividend is Monday, July 29th. This represents a $0.24 dividend on an annualized basis and a dividend yield of 0.62%. Simulations Plus’s payout ratio is 50.00%.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently made changes to their positions in the business. EntryPoint Capital LLC acquired a new position in Simulations Plus in the 1st quarter valued at about $57,000. Allspring Global Investments Holdings LLC bought a new stake in shares of Simulations Plus during the first quarter worth approximately $70,000. Connecticut Wealth Management LLC bought a new position in shares of Simulations Plus during the first quarter worth approximately $204,000. Janney Montgomery Scott LLC acquired a new stake in Simulations Plus during the 1st quarter worth approximately $208,000. Finally, Canton Hathaway LLC boosted its stake in Simulations Plus by 25.0% in the 4th quarter. Canton Hathaway LLC now owns 5,000 shares of the technology company’s stock valued at $224,000 after purchasing an additional 1,000 shares during the period. 78.08% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

SLP has been the subject of a number of research analyst reports. JMP Securities assumed coverage on shares of Simulations Plus in a research note on Tuesday, July 16th. They issued a “market perform” rating for the company. Craig Hallum restated a “buy” rating and set a $56.00 target price on shares of Simulations Plus in a report on Wednesday, July 3rd. William Blair initiated coverage on shares of Simulations Plus in a report on Friday, June 28th. They issued an “outperform” rating on the stock. KeyCorp assumed coverage on shares of Simulations Plus in a research report on Monday, July 29th. They set an “overweight” rating and a $47.00 target price for the company. Finally, Oppenheimer upped their price objective on Simulations Plus from $55.00 to $65.00 and gave the company an “outperform” rating in a report on Thursday, June 13th. Two equities research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus price target of $56.00.

Simulations Plus Company Profile

Simulations Plus, Inc develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through two segments, Software and Services. It offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products.